切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2025, Vol. 19 ›› Issue (03) : 290 -293. doi: 10.3877/cma.j.issn.1674-3946.2025.03.016.

论著

胸腹腔镜联合食管残胃胸内吻合治疗SiewertⅡ型食管胃结合部腺癌的近期疗效分析
施浩1, 冯晨明1, 解曙哲1, 刘俊杰1, 赵强1,(), 韩超1,()   
  1. 1. 046000 山西长治,长治医学院附属和平医院胃肠外科
  • 收稿日期:2024-09-05 出版日期:2025-06-26
  • 通信作者: 赵强, 韩超
  • 基金资助:
    山西省自然科学基金资助项目(20210302124006)博士启动资金(BS202125)

Analysis of the short-term efficacy of thoracoscopic and laparoscopic combined with intrathoracic anastomosis of the esophagus and residual stomach in the treatment of siewert type Ⅱ adenocarcinoma of the esophagogastric junction

Hao Shi1, Chenming Feng1, Shuzhe Xie1, Junjie Liu1, Qiang Zhao1,(), Chao Han1,()   

  1. 1. Department of Gastrointestinal Surgery,Heping Hospital Affiliated to Changzhi Medical College,Changzhi Shaanxi Province 046000,China
  • Received:2024-09-05 Published:2025-06-26
  • Corresponding author: Qiang Zhao, Chao Han
引用本文:

施浩, 冯晨明, 解曙哲, 刘俊杰, 赵强, 韩超. 胸腹腔镜联合食管残胃胸内吻合治疗SiewertⅡ型食管胃结合部腺癌的近期疗效分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 290-293.

Hao Shi, Chenming Feng, Shuzhe Xie, Junjie Liu, Qiang Zhao, Chao Han. Analysis of the short-term efficacy of thoracoscopic and laparoscopic combined with intrathoracic anastomosis of the esophagus and residual stomach in the treatment of siewert type Ⅱ adenocarcinoma of the esophagogastric junction[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(03): 290-293.

目的

探讨胸腹腔镜联合食管残胃胸内吻合手术治疗SiewertⅡ型食管胃结合部腺癌(AEG)的近期疗效。

方法

回顾性分析2021年6月至2023年4月33例SiewertⅡ型食管胃结合部腺癌患者的临床资料。采用SPSS25.0统计学软件进行数据分析。围手术期指标、胃食管反流病(GERD)量表评分等计量资料以(±s)表示,行配对t检验;术后并发症分级采用Clavien-Dindo 分级系统评估,计数资料采用[例(%)]表示。P<0.05为差异有统计学意义。

结果

33例患者均完成胸腹腔镜联合食管残胃胸内吻合术。手术时间(262.3±37.3)min,术中出血量(178.8±111.8)ml,术后住院时间(11.4±3.6)d。2(6.1%)例患者术后发生吻合口漏,1(3.0%)例患者术后发生肺部感染,均为Clavien-DindoⅡ级,经抗炎、营养等对症支持治疗后治愈。所有患者术后切缘均为阴性,无吻合口狭窄,无吻合口出血及死亡。

结论

胸腹腔镜联合食管残胃胸内吻合手术在SiewertⅡ型AEG的治疗中安全可行,不会增加术后并发症的发生风险。

Objective

To explore the short-term efficacy of thoracoscopic and laparoscopic combined with intrathoracic anastomosis of the esophagus and residual stomach in the treatment of Siewert type Ⅱ adenocarcinoma of the esophagogastric junction (AEG).

Methods

The clinical data of 33 patients with Siewert type Ⅱ adenocarcinoma of the esophagogastric junction from June 2021 to April 2023 were retrospectively analyzed.The statistical software SPSS25.0 was used for data analysis.Measurement data such as perioperative indexes and the scores of gastroesophageal reflux disease (GERD) scale were expressed as(±s),and paired t test was performed.The postoperative complication grading was evaluated using the Clavien-Dindo grading system,and the counting data were expressed as[ cases (%)].A P value less than 0.05 was considered statistically significant.

Results

All 33 patients completed the thoracoscopic and laparoscopic combined with intrathoracic anastomosis of the esophagus and residual stomach.The operation time was (262.3±37.3)minutes,the intraoperative blood loss was (178.8±111.8) ml,and the postoperative hospital stay was (11.4±3.6)days.Anastomotic leakage occurred in 2 (6.1%) patients and pulmonary infection occurred in 1 (3.0%) patient after surgery,both of which were Clavien-Dindo grade Ⅱ,and they were cured after symptomatic supportive treatments such as anti-inflammatory and nutritional treatments.All patients had negative surgical margins postoperatively,without anastomotic stricture,anastomotic bleeding or death.

Conclusion

Thoracoscopic and laparoscopic combined with intrathoracic anastomosis of the esophagus and residual stomach is safe and feasible in the treatment of Siewert type Ⅱ AEG,and it will not increase the risk of postoperative complications.

表1 33例食管胃结合部腺癌手术患者基线资料
图1 管状胃及胸腔内操作步骤 注:①为制作管状胃;②为游离下段食管;③为将管状胃拉至胸腔;④为腔内直线切割闭合器吻合食管残胃;⑤为倒刺线加固闭合共同开口;⑥为吻合完成效果
图2 患者出院前造影,吻合口通畅,造影剂通过性良好
图3 胃镜下黏膜破损
表2 33例食管胃结合部腺癌手术患者术后1年肿瘤标记物水平
[1]
Sung H,Ferlay J,Siegel RL,et al.Global Cancer Statistics 2020:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J/OL].CA:A Cancer Journal for Clinicians,2021: 209-249.
[2]
中华医学会肿瘤学分会早诊早治学组.胃癌早诊早治中国专家共识(2023版)[J].中华消化外科杂志,2024,23(01): 23-36.
[3]
中华医学会外科学分会腹腔镜与内镜外科学组.Siewert Ⅱ型食管胃结合部腺癌腔镜手术治疗中国专家共识(2023版)[J].中华消化外科杂志,2023,22(07): 799-809.
[4]
孙益红.食管胃结合部腺癌的外科治疗原则[J/CD].中华普外科手术学杂志(电子版),2010,4(02): 119-122.
[5]
韦静涛,季鑫,季加孚.不断提高中国胃癌外科手术治疗规范化[J/CD].中华普外科手术学杂志(电子版),2022,16(03):237-241.
[6]
Dindo D,Demartines N,Clavien PA.Classification of Surgical Complications [J/OL].Annals of Surgery,2004: 205-213.
[7]
中华医学会消化病学分会胃肠动力学组,胃肠功能性疾病协作组,食管疾病协作组.中国胃食管反流病诊疗规范[J].中华消化杂志,2023,43(09): 588-598.
[8]
Armstrong D,Bennett J,Blum A,et al.The endoscopic assessment of esophagitis: A progress report on observer agreemen[tJ/OL].Gastroenterology,1996: 85-92.
[9]
Koyanagi K,Kato F,Kanamori J,et al.Clinical significance of esophageal invasion length for the prediction of mediastinal lymph node metastasis in Siewert type II adenocarcinoma:A retrospective single-institution study[J/OL].Annals of Gastroenterological Surgery,2018: 187-196.
[10]
Kurokawa Y,Sasako M,et al.Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardi[aJ/OL].British Journal of Surgery,2015,102(4): 341-348.
[11]
黄云,杨坤秋,刘刚.腹腔镜下经左侧膈肌入路胃食管结合部癌根治术[J/CD].中华普外科手术学杂志(电子版),2022,16(03): 257.
[12]
Lin JP,Lin JX,Ma YB,et al.Prognostic significance of pre- and post-operative tumour markers for patients with gastric cance[rJ/OL].British Journal of Cancer,2020: 418-425.
[13]
吴舟桥,李子禹,季加孚.对胃癌术后并发症的再认识[J].中华胃肠外科杂志,2017,20(02): 121-124.
[14]
中华医学会外科学分会,中国研究型医院学会感染性疾病循证与转化专业委员会,中华外科杂志编辑部.外科常见腹腔感染多学科诊治专家共识[J].中华外科杂志,2021,59(03):161-178.
[15]
张伟,蔡振花.早期胃癌患者腹腔镜胃癌根治术后复发相关因素分析[J/CD].中华普外科手术学杂志(电子版),2020,14(06): 566-568.
[16]
张正华,魏大中,徐美清,等.胸腹腔镜联合Ivor-Lewis食管癌根治术的临床应用[J].中华解剖与临床杂志,2015,20(01):54-58.
[17]
Chen XF,Zhang B,Chen ZX,et al.Gastric Tube Reconstruction Reduces Postoperative Gastroesophageal Reflux in Adenocarcinoma of Esophagogastric Junction[J/OL].Digestive Diseases and Sciences,2012: 738-745.
[18]
周佳宏,李民.胸科手术后肺部并发症的研究进展[J].中国微创外科杂志,2023,23(06): 469-474.
[1] 马海龙, 吴少锋, 王茂, 陈学锋, 代引海. 腹腔镜近端胃切除不同消化道重建围手术期安全性及抗反流效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 274-277.
[2] 李峥, 马晋峰. 基于炎症反应评分系统构建预测根治性术后食管胃结合部腺癌患者预后的列线图模型[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 170-175.
[3] 艾世超, 孙艺文, 宋鹏, 沈晓菲, 刘颂, 孙锋, 陆晓峰, 王萌, 管文贤. 静脉注射吲哚菁绿导航胃癌根治术的单臂开放前瞻性研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 166-169.
[4] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[5] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[6] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[7] 燕速, 霍博文. 腹腔镜食管胃结合部腺癌根治性切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 13-13.
[8] 蔡永芹, 王君菊, 张敬敬. 不同下纵隔淋巴结清扫顺序在Siewert Ⅱ型食管胃结合部腺癌中应用效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 562-565.
[9] 黄一博, 李至彦, 林晨, 陶亮, 王萌, 管文贤. 胃癌根治术中淋巴结示踪剂的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 586-588.
[10] 丁关棣, 黄云, 曹震, 刘刚. 胃癌根治术后感染性并发症预测:基于真实世界数据的Nomogram模型开发与验证[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 261-266.
[11] 黄昌明, 郑华龙, 郑红红. 腹腔镜胃癌全胃切除术消化道重建术式选择与策略[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(02): 123-126.
[12] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[13] 周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[14] 李临川, 李戊阳, 程玉刚, 朱健康, 张光永. 近端胃切除术后消化道重建方式的现状与展望[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(03): 135-140.
[15] 曹猛, 郭杰东, 朱灿, 许腾, 樊瑞智, 江涛, 宋军, 徐溢新. 完全腹腔镜右半结肠切除术中顺蠕动侧侧吻合的有效性及安全性评价[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 315-319.
阅读次数
全文


摘要